Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2023GlobeNewsWire • 08/10/23
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023GlobeNewsWire • 05/22/23
Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended December 31, 2022GlobeNewsWire • 02/03/23
These Were the Five Best and Worst Performing Small-cap Stocks in October 202224/7 Wall Street • 11/08/22
Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14thGlobeNewsWire • 11/07/22
Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022GlobeNewsWire • 11/04/22
UBS Analyst Gets Immunovant Prediction Horribly Wrong After Stock Price Doubles After Downgrade24/7 Wall Street • 10/06/22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common StockGlobeNewsWire • 10/04/22